EP2608799
INTERLEUKIN-13 RECEPTOR ALPHA 2 PEPTIDE-BASED BRAIN CANCER VACCINES
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
23.8.2011EP published:
12.12.2018EP application number:
11820530.1
EPO information:
European Patent Register
Max expiry date:
22.8.2031
Title:
INTERLEUKIN-13 RECEPTOR ALPHA 2 PEPTIDE-BASED BRAIN CANCER VACCINES
Timeline
Today
23.8.2011EP application
12.12.2018EP Publication
Owner
Name:
University of Pittsburgh - Of the Commonwealth System of Higher EducationAddress:
200 Gardner Steel Conference Center, 15260, Pittsburgh, PA, US
Inventor
Name:
OKADA, HidehoAddress:
PittsburghPennsylvania, US
Priority
Number:
376582 PDate:
24.8.2010Country:
US
Classification
Categories:
A61K 38/08, A61K 39/39, A61K 39/395, A61P 35/00